# Title

 Food and Drugs. PART 800â€”GENERAL


# ID

 CFR-2018-title21-vol8.Pt. 800


# Structured Analysis Summary

| Type        | Values                                                                                                         |
|:------------|:---------------------------------------------------------------------------------------------------------------|
| Constraints | ['before', 'exceeds', 'within', 'maximum', 'later than', 'less than', 'after', 'minimum', 'exceed', 'greater'] |
| Duration    | ['30.0 day', '2.0 year', '2 minute', '2.0 minute', '10.0 day', '20.0 day']                                     |
| Condition   | ['until', 'unless', 'where', 'as soon as', 'subject to', 'when', 'if']                                         |
| Entities    | ['Visual', 'Request', 'Food', 'United States Government', 'Finger', 'Paragraph']                               |
| Date        | ['1983-05-05', '1983-02-07', '1964-09-01', '1984-02-06']                                                       |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                            |
|:--------------|:-------------------------------------------------------------------------------------------------------------------|
| within        | are not sterile may be regarded as adulterated within the meaning of section 501(c) of the Federal                 |
| within        | are not sterile may be regarded as adulterated within the meaning of section 501(c) of the Federal                 |
| within        | package is opened and be labeled, on or within the retail package, so as to afford adequate                        |
| after         | the likelihood of substitution of a tamper-resistant feature after tampering, the indicator or barrier to entry is |
| after         | lens solution packaged for retail sale on or after that date, except for the requirement in paragraph              |
| after         | that is packaged for retail sale on or after  that date.                                                           |
| after         | this section packaged for retail sale on or after that date, except that the requirement for a                     |
| after         | this section packaged for retail sale on or after that date, except that the requirement for a                     |
| after         | held for sale at retail level on or after that date that was packaged for retail sale                              |
| before        | that date that was packaged for retail sale before  May 5, 1983.                                                   |
| after         | Products packaged for retail sale  after May 5, 1983, are required to be in                                        |
| minimum       | FDA considers the following to be the  minimum materials required for this test : (i) A                            |
| after         | Immediately  after adding the water, examine the glove for water                                                   |
| minimum       | Do not squeeze the glove; use only  minimum manipulation to spread the fingers to check for                        |
| after         | Make a second observation for leaks 2 minutes after  the water is added to the glove.                              |
| minimum       | Use only  minimum  manipulation of the fingers to check for leaks.                                                 |
| minimum       | By Attributes.&#8221; (2) Sample sizes, inspection levels, and minimum  AQLs.                                      |
| minimum       | FDA considers a 1.5 AQL to be the minimum level of quality acceptable for surgeons' gloves and                     |
| minimum       | FDA considers a 1.5 AQL to be the minimum level of quality acceptable for surgeons' gloves and                     |
| exceeds       | gloves found in the tested sample meets or exceeds the applicable rejection number at the 1.5 AQL                  |
| within        | and (c) of this section, are considered adulterated within  the meaning of section 501(c) of the act.              |
| exceed        | gloves found in the tested sample does not exceed the acceptance number in the appropriate tables in               |
| within        | reconditioned lot of medical gloves to be adulterated within the meaning of section 501(c) of the act              |
| exceeds       | gloves found in the tested sample meets or exceeds the applicable rejection number in the tables following         |
| exceed        | be for a reasonable period that may not exceed 20 calendar days after the detention order is                       |
| after         | period that may not exceed 20 calendar days after the detention order is issued, unless the FDA                    |
| greater       | district the devices are located determines that a greater period is required to seize the devices, to             |
| exceed        | The entire detention period may not  exceed 30 calendar days, except when the detention period                     |
| before        | paragraph (j) of this section, terminate a detention before  the expiration of the detention period.               |
| before        | A detention order,  before issuance, shall be approved by the FDA District                                         |
| within        | shall be obtained and confirmed by written memorandum within  FDA as soon as possible.                             |
| within        | Director in whose district the devices are located within 5 working days of receipt of a detention                 |
| within        | shall request either that a hearing be held within 5 working days after the appeal is filed                        |
| after         | a hearing be held within 5 working days after the appeal is filed or that the hearing                              |
| later than    | at a later date, which shall not be later than 20 calendar days after receipt of a detention                       |
| after         | a hearing be held within 5 working days after the appeal is filed or that the hearing                              |
| less than     | be required to be held at a time less than 2 working days after receipt of the request                             |
| after         | at a time less than 2 working days after receipt of the request for a hearing, does                                |
| within        | hearing and requests that the hearing be held within 5 working days after the appeal is filed,                     |
| after         | the hearing be held within 5 working days after the appeal is filed, the presiding officer shall,                  |
| within        | hearing and requests that the hearing be held within 5 working days after the appeal is filed,                     |
| later than    | that the hearing be held at a date later than within 5 working days after the appeal is                            |
| after         | a date later than within 5 working days after the appeal is filed, but not later than                              |
| later than    | that the hearing be held at a date later than within 5 working days after the appeal is                            |
| after         | a date later than within 5 working days after the appeal is filed, but not later than                              |
| within        | decide whether to affirm or revoke the detention within 5 working days after the conclusion of the                 |
| after         | or revoke the detention within 5 working days after  the conclusion of the hearing.                                |
| within        | on the appeal affirming or revoking the detention within 5 working days after the filing of the                    |
| after         | or revoking the detention within 5 working days after  the filing of the appeal.                                   |
| within        | this paragraph, no person shall move detained devices within or from the place where they have been                |
| within        | form for shipment, the manufacturer may move them within the establishment where they are detained to complete     |
| after         | required tags shall accompany the devices during and after movement and shall remain with the devices until        |
| after         | on any distribution of the devices before and after the detention period, records on the correlation of            |
| before        | misbranded, records on any distribution of the devices before and after the detention period, records on the       |
| after         | on any distribution of the devices before and after the detention period, records on the correlation of            |
| maximum       | under this paragraph shall be maintained for a maximum period of 2 years after the issuance of                     |
| after         | maintained for a maximum period of 2 years after the issuance of the detention order or for                        |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-----------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2 minute   | The horizontal support rod must be capable of holding the weight of the total number of gloves that will be suspended at any one time, e.g., five gloves suspended will weigh about 5 kilograms (kg);                                                                                                                                                                                                                                             |
|            |               (v) Timer capable of measuring two minute intervals.                                                                                                                                                                                                                                                                                                                                                                                |
| 2.0 minute | (B) Make a second observation for leaks 2 minutes after the water is added to the glove.                                                                                                                                                                                                                                                                                                                                                          |
| 20.0 day   | The detention is to be for a reasonable period that may not exceed 20 calendar days after the detention order is issued, unless the FDA District Director in whose district the devices are located determines that a greater period is required to seize the devices, to institute injuction proceedings, or to evaluate the need for legal action, in which case the District Director may authorize detention for 10 additional calendar days. |
| 10.0 day   | The additional 10-calendar-day detention period may be ordered at the time the detention order is issued or at any time thereafter.                                                                                                                                                                                                                                                                                                               |
| 30.0 day   | The entire detention period may not exceed 30 calendar days, except when the detention period is extended under paragraph (g)(6) of this section.                                                                                                                                                                                                                                                                                                 |
| 20.0 day   | If the appeal includes a request for an informal hearing, as defined in section 201(x) of the act, the appellant shall request either that a hearing be held within 5 working days after the appeal is filed or that the hearing be held at a later date, which shall not be later than 20 calendar days after receipt of a detention order.                                                                                                      |
| 20.0 day   | (6) If the appellant requests a regulatory hearing and requests that the hearing be held at a date later than within 5 working days after the appeal is filed, but not later than 20 calendar days after receipt of a detention order, the presiding officer shall hold the hearing at a date agreed upon by FDA and the appellant.                                                                                                               |
| 20.0 day   | The detention period extends to the date of the decision even if the 5-working-day period for making the decision extends beyond the otherwise applicable 20-calendar-day or 30-calendar-day detention period.                                                                                                                                                                                                                                    |
| 30.0 day   | The detention period extends to the date of the decision even if the 5-working-day period for making the decision extends beyond the otherwise applicable 20-calendar-day or 30-calendar-day detention period.                                                                                                                                                                                                                                    |
| 2.0 year   | (2) Records required under this paragraph shall be maintained for a maximum period of 2 years after the issuance of the detention order or for such other shorter period as FDA directs.                                                                                                                                                                                                                                                          |
| 2.0 year   | When FDA terminates the detention or when the detention period expires, whichever occurs first, FDA will advise all persons required under this paragraph to keep records concerning that detention whether further recordkeeping is required for the remainder of the 2-year, or shorter, period.                                                                                                                                                |


## Condition

| Condition   | Context                                                                                                                                   |
|:------------|:------------------------------------------------------------------------------------------------------------------------------------------|
| if          | and Drug Administration concludes that all such preparations, if they are not sterile, fall below their professed                         |
| if          | below their professed standard of purity or quality if  they are not sterile.                                                             |
| unless      | These articles, which are regulated as medical devices  unless packaged with the drugs with which they are                                |
| until       | should be packaged so as to maintain sterility until the package is opened and be labeled, on                                             |
| if          | shall package the product in a tamper-resistant package, if this product is accessible to the public while                                |
| if          | having an indicator or barrier to entry which, if breached or missing, can reasonably be expected to                                      |
| when        | shall be designed to and shall remain intact when handled in a reasonable manner during manufacture, distribution,                        |
| if          | be so placed that it will be unaffected if the tamper-resistant feature of the package is breached                                        |
| subject to  | (e) Products  subject to  approved premarket approval applications.                                                                       |
| subject to  | Holders of approved premarket approval applications for products  subject to this section are required to submit supplements to           |
| unless      | the requirement of paragraph (b) of this section unless these changes do not affect the composition of                                    |
| subject to  | Each product  subject to this section is required to comply with the                                                                      |
| subject to  | effective on May 5, 1983 for each product subject to this section packaged for retail sale on or                                          |
| subject to  | effective on May 5, 1983 for each product subject to this section packaged for retail sale on or                                          |
| subject to  | effective on February 6, 1984 for each product subject to this section that is held for sale at                                           |
| when        | recommends that health care workers wear medical gloves when touching blood or other body fluids, mucous membranes,                       |
| when        | recommends that health care workers wear medical gloves when touching blood or other body fluids, mucous membranes,                       |
| when        | recommends that health care workers wear medical gloves when touching blood or other body fluids, mucous membranes,                       |
| when        | For this test, defects include leaks detected  when tested in accordance with paragraph (b)(3) of this                                    |
| when        | gloves that adhere to each other and tear when separated, or other visual defects that are likely                                         |
| if          | (a cylinder of another size may be used if it accommodates both cuff diameter and any water                                               |
| if          | (do not support the filled glove while transferring). if                                                                                  |
| when        | and inspect samples of medical gloves, and determine when the gloves are acceptable as set out in                                         |
| when        | a lot of medical gloves to be adulterated when the number of defective gloves found in the                                                |
| subject to  | adulterated under section 501(c) of the act are subject to administrative and judicial action, such as detention of                       |
| when        | paragraph (d)(2)(i) of this section, to be acceptable when the number of defective gloves found in the                                    |
| when        | the meaning of section 501(c) of the act when the number of defective gloves found in the                                                 |
| until       | during inspections that may be adulterated or misbranded, until the Food and Drug Administration (FDA) has had                            |
| if          | concerning the devices, and to initiate legal action, if  appropriate.                                                                    |
| until       | as authorized under paragraph (h) of this section, until FDA terminates the detention order under paragraph (j)                           |
| when        | may be ordered in accordance with this section when an authorized FDA representative, during an inspection under                          |
| unless      | calendar days after the detention order is issued, unless the FDA District Director in whose district the                                 |
| when        | period may not exceed 30 calendar days, except when the detention period is extended under paragraph (g)(6)                               |
| where       | operator, or agent in charge of the place where  the devices are located.                                                                 |
| where       | operator, or agent in charge of the place where the devices are detained, a copy of the                                                   |
| if          | or the user of the devices is d if ferent from the owner, operator, or agent in                                                           |
| if          | the owner of the vehicle or other carrier, if  their identities can be readily determined.                                                |
| if          | the owner of the vehicle or other carrier, if  their identities can be readily determined.                                                |
| as soon as  | obtained and confirmed by written memorandum within FDA as soon as  possible.                                                             |
| if          | who would be entitled to claim the devices, if  seized, may appeal a detention order.                                                     |
| if          | would have legitimate authority to claim the devices if  seized.                                                                          |
| if          | render a decision affirming or revoking the detention. if                                                                                 |
| if          | date agreed upon by FDA and the appellant. if                                                                                             |
| if          | extends to the date of the decision even if the 5-working-day period for making the decision extends                                      |
| if          | working days after the filing of the appeal. if                                                                                           |
| if          | or the detention period expires, whichever occurs first. if                                                                               |
| until       | detention order, the devices continue to be detained until FDA terminates the detention under paragraph (j) of                            |
| if          | the detention under paragraph (j) of this section. if                                                                                     |
| where       | move detained devices within or from the place where they have been ordered detained until FDA terminates                                 |
| until       | the place where they have been ordered detained until FDA terminates the detention under paragraph (j) of                                 |
| if          | work needed to put them in final form. if                                                                                                 |
| where       | the manufacturer may move them within the establishment where they are detained to complete the work needed                               |
| if          | responsible for their movement shall immediately orally not if y the official who approved the movement of                                |
| unless      | or the detention period expires, whichever occurs first. unless                                                                           |
| until       | after movement and shall remain with the devices until FDA terminates the detention or the detention period                               |
| when        | If FDA decides to terminate a detention or  when the detention period expires, whichever occurs first, an                                 |
| where       | any factory, warehouse, other establishment, or consulting laboratory where detained devices are manufactured, processed, packed, or held |
| when        | When FDA terminates the detention or  when the detention period expires, whichever occurs first, FDA                                      |
| if          | FDA ordinarily will not require further recordkeeping  if the agency determines that the devices are not                                  |
| unless      | is not necessary to protect the public health, unless the records are required under other regulations in                                 |


## Entities

| Entities                 | Context                                                                                                                  |
|:-------------------------|:-------------------------------------------------------------------------------------------------------------------------|
| Food                     | Food  and Drugs.                                                                                                         |
| Request                  | clearly identified on the envelope as a &#8220; Request for Exemption from Tamper-resistant Rule.&#8221; A petition for  |
| Finger                   | Finger cots, however, are excluded from the test method                                                                  |
| Visual                   | Visual defects and leaks that are observed in the                                                                        |
| United States Government | statement that the devices are detained by the United States Government in accordance with section 304(g) of the Federal |
| Paragraph                | (iv)  Paragraph (g)(4) of this section, rather than &#167;&#8201;16.42(a) of                                             |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1964-09-01 | In a statement of policy issued on September 1, 1964, the Food and Drug Administration ruled that liquid preparations offered or intended for ophthalmic use that are not sterile may be regarded as adulterated within the meaning of section 501(c) of the Federal Food, Drug, and Cosmetic Act (the act), and, further, may be deemed misbranded within the meaning of section 502(j) of the act.                                                                                                                                                 |
| 1983-02-07 | (i) The packaging requirement in paragraph (b) of this section is effective on February 7, 1983 for each contact lens solution packaged for retail sale on or after that date, except for the requirement in paragraph (b) of this section for a distinctive indicator or barrier to entry.                                                                                                                                                                                                                                                          |
| 1983-05-05 | (ii) The packaging requirement in paragraph (b) of this section is effective on May 5, 1983 for each tablet that is to be used to make a contact lens solution and that is packaged for retail sale on or after that date.                                                                                                                                                                                                                                                                                                                           |
| 1983-05-05 | The requirement in paragraph (b) of this section that the indicator or barrier to entry be distinctive by design and the requirement in paragraph (c) of this section for a labeling statement are effective on May 5, 1983 for each product subject to this section packaged for retail sale on or after that date, except that the requirement for a specific label reference to any identifying characteristic is effective on February 6, 1984 for each affected product subject to this section packaged for retail sale on or after that date. |
| 1984-02-06 | The requirement in paragraph (b) of this section that the indicator or barrier to entry be distinctive by design and the requirement in paragraph (c) of this section for a labeling statement are effective on May 5, 1983 for each product subject to this section packaged for retail sale on or after that date, except that the requirement for a specific label reference to any identifying characteristic is effective on February 6, 1984 for each affected product subject to this section packaged for retail sale on or after that date. |
| 1984-02-06 | The tamper-resistant packaging requirement of paragraph (b) of this section is effective on February 6, 1984 for each product subject to this section that is held for sale at retail level on or after that date that was packaged for retail sale before May 5, 1983.                                                                                                                                                                                                                                                                              |
| 1983-05-05 | The tamper-resistant packaging requirement of paragraph (b) of this section is effective on February 6, 1984 for each product subject to this section that is held for sale at retail level on or after that date that was packaged for retail sale before May 5, 1983.                                                                                                                                                                                                                                                                              |
| 1983-05-05 | Products packaged for retail sale after May 5, 1983, are required to be in compliance with all aspects of the regulations without regard to the retail level effective date.                                                                                                                                                                                                                                                                                                                                                                         |


